PME ASX: Why this Rich Lister’s company, Pro Medicus, trades at a PE ratio of 169

  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 90%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.

Already a subscriber?Rich Listers Sam Hupert and Anthony Hall’s medical imaging software company Pro Medicus has become one of the most expensive stocks in the world.

The ascension of Pro Medicus hinges on the success of its core product Visage, which lets radiologists view reports and large image files, generated by X-rays and other scans, from their mobile devices in seconds, enabling them to make diagnostic decisions remotely., at a time when the Aussie company was trading at less than $1.

Its growth in the last year has outstripped that of other top-performing Rich Lister stocks, including Kerry Stokes’ Seven Group, Richard White’s WiseTech and David Tudehope’s Macquarie Technology Group, which all had good years. There have also been some specific share price drivers in the last year, including a major $140 million contract win with Texas hospital operator Baylor Scott & White, general market enthusiasm for artificial intelligence, and an upgrade from the MSCI Global Small Cap Index to the MSCI Global Standard Index.Mr Wilkie believed contracts as large as Baylor Scott & White would be rare wins for Pro Medicus, but Mr Hupert said there were others of this scale in the pipeline.

“They have lots of levers to pull to extract value from the existing customer base,” Mr Kannourakis, who has a 12-month price target of $93, said.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 2. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인